Filing Details

Accession Number:
0001645113-22-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 16:52:28
Reporting Period:
2022-01-03
Accepted Time:
2022-01-05 16:52:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645113 Novocure Ltd NVCR Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1880493 Patrick William Burke 20 Valley Stream Parkway
Suite 300
Malvern PA 19355
Chief Human Resources Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-01-03 17,452 $11.46 43,669 No 4 M Direct
Ordinary Shares Disposition 2022-01-03 2,633 $75.96 41,036 No 4 S Direct
Ordinary Shares Acquisiton 2022-01-03 9,750 $7.15 50,786 No 4 M Direct
Ordinary Shares Disposition 2022-01-03 919 $76.09 49,867 No 4 S Direct
Ordinary Shares Acquisiton 2022-01-03 1,402 $21.60 51,269 No 4 M Direct
Ordinary Shares Disposition 2022-01-03 399 $76.03 50,870 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Options to Buy Ordinary Shares Disposition 2022-01-03 17,452 $0.00 17,452 $11.46
Ordinary Shares Options to Buy Ordinary Shares Disposition 2022-01-03 9,750 $0.00 9,750 $7.15
Ordinary Shares Options to Buy Ordinary Shares Disposition 2022-01-03 1,402 $0.00 1,402 $21.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-02-24 No 4 M Direct
0 2027-02-21 No 4 M Direct
6,098 2027-10-30 No 4 M Direct
Footnotes
  1. Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke.
  2. On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
  3. Fully vested as of the date hereof.